Pacer Advisors, Inc. Puma Biotechnology, Inc. Transaction History

Pacer Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$8.98 - $11.6 $25,476 - $32,909	-2,837 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$9.38 - $13.63 $5,609 - $8,150	-598 Reduced 17.41%	2,837 $28,000
Q4 2020 Jan 20, 2021	SELL	$7.78 - $12.13 $15,202 - $23,702	-1,954 Reduced 36.26%	3,435 $35,000
Q3 2020 Oct 19, 2020	BUY	$9.5 - $11.14 $51,195 - $60,033	5,389 New	5,389 $54,000
Q4 2018 Feb 13, 2019	SELL	$20.07 - $46.7 $109,742 - $255,355	-5,468 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $225,281 - $327,259	5,468 New	5,468 $251,000
Q1 2018 May 14, 2018	SELL	$59.7 - $99.25 $64,177 - $106,693	-1,075 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $100,888 - $142,383	1,075	1,075 $106,000

102

29M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $138M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.